Key result
Elevated serum MMP-9 concentrations were strongly associated with acute coronary syndrome and high acute phase levels predicted fatal major adverse cardiac events.
Case-Control (n=669)
No
Serum MMP-9 and the MMP-9/TIMP-1 molar ratio are elevated in acute coronary syndrome, and their activation potential is associated with fatal cardiovascular outcomes, suggesting value as diagnostic and prognostic biomarkers.
Answers are grounded in this paper and cite their sources.
May support MMP-9 as ACS biomarker; hypothesis-generating and requires prospective validation before clinical use.
Matrix metalloproteinase (MMP)-9 is crucial in atherosclerotic plaque rupture and tissue remodeling after a cardiac event. The balance between MMP-9 and endogenous inhibitor, tissue inhibitors of matrix metalloproteinase 1 (TIMP-1), is important in acute coronary syndrome (ACS). This is an age- and gender-matched case-control study of ACS (N = 669). Patients (45.7%) were resampled after recovery, and all were followed up for 6 years. The molecular forms of MMP-9 were investigated by gelatin zymography. Diagnostically, MMP-9 and the MMP-9/TIMP-1 molar ratio were associated with ACS (OR 5.81, 95% CI 2.65-12.76, and 4.96, 2.37-10.38). The MMP-9 concentrations decreased 49% during recovery (p < 0.001). The largest decrease of these biomarkers between acute and recovery phase (ΔMMP-9) protected the patients from major adverse cardiac events, especially the non-fatal events. The fatal events were associated with in vitro activatable MMP-9 levels (p = 0.028). Serum MMP-9 and the MMP-9/TIMP-1 molar ratio may be valuable in ACS diagnosis and prognosis. High serum MMP-9 activation potential is associated with poor cardiovascular outcome.
No takes yet. Share an insight, caveat, or question.
Lahdentausta et al. (2018) conducted a case-control in Acute Coronary Syndrome (n=669). Elevated serum MMP-9 vs. Controls without coronary heart disease was evaluated on Association with Acute Coronary Syndrome (ACS) (OR 5.81, 95% CI 2.65-12.76, p=<0.001). Elevated serum MMP-9 concentrations were strongly associated with acute coronary syndrome and high acute phase levels predicted fatal major adverse cardiac events.
Synapse has enriched 10 related papers. Consider them for comparative context: